Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials

HAYWARD, Calif. (PRWEB) October 18, 2018 Predicine, a molecular insights company, announced today that its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received accreditation from the College of American Pathologists (CAP) for meeting the highest standards in…

Source link

Related posts

‘Ötzi’ the Iceman’s last meal consisted of fat, wild meat, cereals


Teens with heart disease improve exercise capacity in large clinical trial


Protein Structural Information and Evolutionary Landscape by In Vitro Evolution


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy